Home Galectin Therapeutics

Galectin Therapeutics

In operation
Post-IPO Round
Drug Developer

Basic Information

Galectin Therapeutics is a biotechnology company focused on discovery and development. We leverage our leadership in galectin science and drug development to create new therapies that improve the lives of patients with chronic liver disease, skin conditions, and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biological and pathological functions.
Galectin Therapeutics Inc.
Georgia,United States of America
15~50 people
December 01, 2000
shlevin@galectintherapeutics.com